University of Maryland School of Medicine logo
Emergency Medicine
All Departments
UMSOM Assistant

UMEM Educational Pearls

  • Home
  • Departments
  • Emergency Medicine
  • CME
  • UMEM Educational Pearls
  • CME
  • Courses and Conferences
  • Free Open Access Medical Education
  • UMEM Educational Pearls

Search


Subscribe to daily UMEM Pearls (FREE!) via:

Mailing List

Previous |  1 |  2 |  3 |  4 |  5 |  6 |  ... |  241 |  Next

Title: TBI and brain aging

Category: Trauma

Posted: 11/19/2026 by Robert Flint, MD

Using MRI, patient self assessment and a neural network, 157 brain injured patients were evaluated for their predicted brain age vs their actual brain age over the course of 18 months. These 157 patients showed older (less healthy) brain age compared to their actual age. 
Further evidence that traumatic brain injury has long term structural, functional and neurocognitive effects.

Show References

Samuel I, Pollin K, Chun T, et al. Accelerated brain aging with functional and cognitive decline after traumatic brain injury. Trauma. 2026;0(0). doi:10.1177/14604086261494740



Title: Does having an EMS eCPR referral protocol impact those patients who are not put on pump?

Category: EMS

Keywords: DSD, refractory VF, ECMO, ECPR (PubMed Search)

Posted: 11/18/2026 by Jenny Guyther, MD (Updated: 11/18/2026)

Bottom line: Implementing an eCPR program does not harm non-eCPR cardiac arrest patients — and may improve their outcomes, particularly with hands on training.

Show Additional Information

In this analysis of 30,855 OHCA patients in Los Angeles County, treatment by a pilot eCPR unit after program implementation was not associated with worse survival-to-discharge compared to pre-implementation (OR 1.14, 95% CI 0.99–1.34). This addresses a critical concern that diverting resources and attention toward eCPR could inadvertently worsen care for the vast majority of OHCA patients who do not meet eCPR criteria. 

The implementation model matters — hands-on paramedic training and direct access to mechanical compression devices (MCDs) may produce a "halo effect." In a prespecified subgroup analysis excluding one agency that deployed MCDs only on supervisor units without paramedic hands-on training, the association with improved survival became significant (OR 1.61, 95% CI 1.37–1.95). This suggests that the training and equipment provided as part of eCPR program implementation — particularly scenario-based resuscitation training and MCD familiarity — may have spillover benefits that improve resuscitation quality for all cardiac arrest patients, not just eCPR candidates.

EMS systems should consider eCPR program development as a system-wide quality improvement opportunity, not just a niche intervention. Only 7% of OHCA patients in this cohort had a shockable rhythm, and only a small fraction would ever qualify for eCPR. Yet the infrastructure investments required for eCPR readiness — protocol development, hands-on training, and MCD deployment — appear to benefit the broader OHCA population. This aligns with the 2025 AHA Guidelines emphasis that effective ECPR programs should achieve "excellence along the other links in the Chain of Survival" as a foundation for the program.

Show References

Tolles J, Goebel M, Johnson NJ, Abramson TM, Eisner D, Ghurabi W, Gudzenko V, Kazan C, Mehra A, Sanko S, Shavelle D, Torbati S, Bosson N. Impact of an eCPR Pilot Program on Outcomes After Out-of-Hospital Cardiac Arrest for Patients Who Do Not Receive eCPR in a Large, Urban EMS System. Prehosp Emerg Care. 2026;30(3):414-421. doi: 10.1080/10903127.2025.2592239. Epub 2025 Dec 12. PMID: 41284758.



Title: Vitamin K Deficiency Bleeding is Back! Don't miss this life threatening diagnosis in your PED.

Category: Pediatrics

Keywords: pediatrics, vitamin K deficiency, bleeding, neonates (PubMed Search)

Posted: 11/17/2026 by Kat Stephanos, MD (Updated: 11/17/2026)

Bottom line: You must consider vitamin K deficiency bleeding in neonates, and be prepared to treat

IM Vitamin K refusal is on the rise in neonates - now up to 1 in 20 infants will not receive vitamin K with as many as 1 in 60 patients who did not receive the injection having some form of clinical bleeding.

Bleeding can present as early (<24h), classic (2-7 days), or late (up to 6 months) so consider this in any bruising, bleeding, hematemesis, melena, or infants with irritability, vomiting or fussiness with concern for intracranial bleeding. 

Patients who received oral vitamin K who present with bleeding should be presumed to be vitamin K deficient. 

There is no pattern of bleeding/bruising/ICH that suggests Vitamin K deficiency over other bleeding disorders or trauma. 

prolonged PT and INR suggest Vitamin K deficiency. 

Bleeding should be treated based on severity

  • mild to moderate bleeding, or plan for operative/procedural interventions - give IV vitamin K
  • severe bleeding- treat bleeding with transfusions as needed, give IV vitamin K, give FFP or 4 factor PCC

When giving IV vitamin K there is a risk of anaphylaxis so the patient should be monitored, though there is no evidence for use of any pre-medication.

Show References

Araki S, Shirahata A. Vitamin K Deficiency Bleeding in Infancy. Nutrients. 2020 Mar 16;12(3):780.



Title: Mind the Gap

Category: Critical Care

Posted: 11/17/2026 by Jon Hurst, MD (Updated: 11/17/2026)

The anion gap (AG) represents the difference between measured cations and measured anions in the serum, reflecting the concentration of unmeasured anions.

A normal anion gap is typically 10–12 mmol/L, although reference ranges may vary.

AG = Sodium - (Chloride + Bicarb)

An elevated anion gap generally suggests an underlying metabolic acidosis due to the accumulation of unmeasured anions.

There are several situations that can affect the interpretation and calculation of the anion gap:

1. Correct for albumin.

  • A patient's expected normal anion gap can be approximated as:
    Normal AG = serum albumin × 3 (albumin in g/dL).

2. Use the measured sodium, not corrected sodium.

  • When calculating the anion gap, use the measured sodium concentration rather than the corrected sodium concentration.

3. Common causes of a low anion gap (AG less than 3 mmol/L):

  • Laboratory error (most common)
  • Hypoalbuminemia
  • Electrolyte derangements: hyperkalemia, hypercalcemia, and hypermagnesemia
  • Monoclonal gammopathies (e.g., multiple myeloma)
  • Bromide-containing medications:
    • Pyridostigmine
    • Ipratropium/tiotropium
    • Dextromethorphan
    • Rocuronium
  • Lithium toxicity
  • Salicylate poisoning (with certain laboratory assays)
  • Iodide exposure

Show Additional Information

1. Anion gap adjustment for albumin

  • Albumin is the major unmeasured anion in serum and contributes significantly to the anion gap. Therefore, when serum albumin is low, the patient's expected anion gap is also lower.
  • There are two commonly used approaches to account for albumin:
    • Corrected AG = Measured AG + 2.5 × (4.0 - Measured Albumin)
    • Patient's expected normal AG = Measured Albumin × 3
  • Example: If a patient's measured albumin is 2 g/dL, their expected normal anion gap would be approximately 6 mmol/L (rather than 12 mmol/L).

2. Anion gap in pseudohyponatremia and hyperglycemia

  • Pseudohyponatremia occurs when the measured sodium concentration is falsely low due to laboratory measurement interference, typically in the setting of severe hyperlipidemia or hyperproteinemia.
  • Hyperglycemia causes a low sodium concentration due to osmotic shifts (water is drawn out of cells into the extracellular space due to the hypertonicity of hyperglycemia). This results in translocational (or dilutional) hyponatremia. 
  • Although both conditions can result in a low measured sodium concentration, their underlying mechanisms are different. Pseudohyponatremia is a laboratory artifact, whereas hyperglycemia causes a true decrease in serum sodium concentration due to water redistribution.
  • In both pseudohyponatremia and dilutional hyponatremia, when calculating the anion gap, use the measured sodium concentration rather than the corrected sodium concentration.

3. Common causes of a low anion gap (list is not exhaustive)

  • Laboratory error: The most common cause of a low anion gap. Consider repeating the measurement if the result is unexpected.
  • Hypoalbuminemia: Decreased albumin results in fewer unmeasured anions, lowering the anion gap.
  • Severe electrolyte derangements: Hyperkalemia, hypercalcemia, and hypermagnesemia can increase unmeasured cations, thereby lowering the anion gap. 
  • Multiple myeloma: Positively charged monoclonal immunoglobulins (paraproteins) can act as unmeasured cations, lowering the anion gap.
  • Pseudohyperchloremia: Certain substances can interfere with chloride measurement, resulting in a falsely elevated chloride concentration and a falsely low anion gap. Examples include:
    • Bromide exposure
    • Iodide exposure
    • Salicylate toxicity (with certain laboratory assays)
  • Lithium toxicity: Lithium is an unmeasured cation thus lowering the anion gap.

Show References

Beck, Laurence H. “Should the Actual or the Corrected Serum Sodium Be Used to Calculate the Anion Gap in Diabetic Ketoacidosis?” Cleveland Clinic Journal of Medicine, vol. 68, no. 8, Aug. 2001, pp. 673–674. https://doi.org/10.3949/ccjm.68.8.673.

Farkas, Josh. “Diagnosis of Metabolic Acid-Base Disorders & AGMA (Including Lactic Acidosis).” EMCrit Project, 29 June 2024, https://emcrit.org/ibcc/agma/.

Haber, Lawrence A., et al. “Evaluating a Low Anion Gap: A Practical Approach.” Cleveland Clinic Journal of Medicine, vol. 90, no. 10, 2 Oct. 2023, pp. 619–623. https://doi.org/10.3949/ccjm.90a.23035.

Nickson, Chris. “Anion Gap.” Life in the Fast Lane (LITFL), 1 Jan. 2019, https://litfl.com/anion-gap/.

Wiederkehr, Michael R., et al. “Pseudohyperchloremia and Negative Anion Gap—Think Salicylate!” The American Journal of Medicine, vol. 134, no. 9, Sept. 2021, pp. 1170–1174. https://doi.org/10.1016/j.amjmed.2021.03.017.



Title: Signs of Aortic Stenosis on POCUS

Category: Ultrasound

Keywords: cardiology; aortic stenosis; POCUS (PubMed Search)

Posted: 11/16/2026 by Alexis Salerno Rubeling, MD

You can look for aortic stenosis quickly with qualitative and quantitative evaluation using POCUS:

Qualitatively

  • Obtain a parasternal long axis or short axis at the level of the base of the heart (Mercedes-Benz sign).
  • Evaluate the aortic valve leaflets
    • Is there calcifications?
    • Are the leaflets mobile?
    • Is there also LV hypertrophy

  • Image shows a parasternal long axis view with thickened aortic valve leaflets and poor leaflet movement.

Quantitatively

  • Obtain an apical 5 chamber view in cardiac mode
  • Place the pulse wave doppler gate just at the LVOT and trace the LVOT VTI

  • Then place the continuous wave doppler gate inside the aortic valve and trace the aortic valve VTI.

  • Calculate the dimensionless index = LVOT VTI/AV VTI
    • Normal 1:1 ratio
    • Mild Stenosis 1:2 ratio
    • Moderate Stenosis 1: 3 ratio
    • Severe Stenosis 1 :4 ratio

There are some limitations with performing these measurements such as mitral regurgitation and LV hypertrophy can reduce the aortic velocity measurement, leading to underestimation of AS severity. The ultrasound beam also needs to be completely parallel to the flow and the measurement is flow dependent.

Show References

Molyneux K,  Beck-Esmay J, et al. Severe aortic stenosis: A narrative review for the emergency clinician. AJEM,2026. https://doi.org/10.1016/j.ajem.2026.11.012. https://www.sciencedirect.com/science/article/abs/pii/S0735675726005929

Furukawa A, Abe Y, Morizane A, Miyaji T, Hosogi S, Ito H. Simple echocardiographic scoring in screening aortic stenosis with focused cardiac ultrasonography in the emergency department. J Cardiol. 2021 Jun;77(6):613-619. doi: 10.1016/j.jjcc.2020.12.006.

Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, Lancellotti P, LeFevre M, Miller F Jr, Otto CM. Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017 Apr;30(4):372-392. doi: 10.1016/j.echo.2017.02.009.



Title: Can you safely watch a hemothorax without chest tube?

Category: Trauma

Keywords: Hemothorax (PubMed Search)

Posted: 11/15/2026 by Robert Flint, MD (Updated: 11/19/2026)

This prospective observational study says yes if it is less than 300 ml. (Calculated with Mergo’s formula of v=d2 xl). 

See this pearl for a refresher on volume calculation  

https://www.medschool.umaryland.edu/em/cme/umem-educational-pearls/?id=4862 

Show References

Journal of Trauma and Acute Care Surgery 101(5):p 797-804, November 2026. | DOI: 10.1097/TA.0000000000004991



Title: “Don’t just do something, sit there”

Category: Orthopedics

Posted: 11/14/2026 by Brian Corwell, MD

Managing common back pain in the ED

Show Additional Information

New guidance and guidelines for the management of acute low back pain from the American Academy of Pain Medicine.

Published in Pain Medicine Sep 2026

Acute low back pain is defined as pain lasting 6 weeks or less, with an episode persisting for more than 24 hours that is preceded and followed by at least 1 month without pain.

In summary these guidelines emphasize:

Heat therapy

Movement (low impact)

OTC medication (NSAIDs)

Some other take home points:

For failure to improve after 2 weeks of above, consider Rx NSAIDs, muscle relaxants, PT, acupuncture.

Bed rest prolongs recovery

Avoid imaging and Rx opioids for most patients on first presentation

     -A brief course of an opioid may be appropriate for severe, disabling pain or for patients unable to use other drugs.

Psychosocial factors best predicted who would develop persistent low back pain: 

     Maladaptive pain coping, low general health status, and psychiatric comorbidities.

Carisoprodol (Soma) and benzodiazepines are actively discouraged

No guideline support for antidepressants or gabapentin in acute setting.

Show References

Andrea C Skelly, Devan Kansagara, Jessica Oswald, Roger Chou, For the Acute Low Back Pain Guideline Project Guideline Development Group , American Academy of Pain Medicine (AAPM) LBP Guideline Consultants , Assessment and Treatment of Acute Low Back Pain: A Multidisciplinary Clinical Practice Guideline, Pain Medicine, 2026



Title: Bicarb in Cardiac Arrest: Time to Call It?

Category: Pharmacology & Therapeutics

Keywords: cardiac arrest, sodium bicarbonate, bicarb (PubMed Search)

Posted: 11/12/2026 by Alicia Pycraft (Updated: 11/12/2026)

A recent RCT published in JAMA evaluated the use of sodium bicarbonate for in-hospital cardiac arrest and found no differences in rates of ROSC, 30-d survival, or survival with a favorable neurologic outcome. The sodium bicarbonate group had higher rates of adverse events such as alkalosis and hypernatremia.   

Bottom line: Routine use of sodium bicarbonate during cardiac arrest is not recommended.

Show Additional Information

Study Design: This was a randomized, parallel-group, double-blind, placebo-controlled trial in Denmark from 2023-2026 that included adult patients who received >/= 1 dose of epinephrine during in-hospital cardiac arrest. Patients with a DNR order, prior enrollment, invasive mechanical circulatory support, or a clinical indication for sodium bicarbonate (SB) were excluded. Patients were randomized 1:1 to either 50 mL (50 mmol) of sodium bicarbonate 8.4% or 50 mL of sodium chloride 0.9% for up to a max of 2 doses.   

Population: A total of 779 patients were eligible for the primary analysis. The median age of the population was 74, most were males (65%), and majority were witnessed arrests (76%). Median time to epinephrine was 6 minutes, and median time to the trial drug was 8 minutes. Most arrests (66%) occurred on the hospital ward and 14% had acidosis prior to cardiac arrest. 

Results: There was no difference in the rate of ROSC between groups, 30-day survival, or survival with a favorable neurologic outcome (Table 1). The sodium bicarbonate group had higher rates of alkalosis (35% vs 20%) and hypernatremia (42% vs. 29%). 

*Reported as n(%)     †Reported as No./total No.(%)

Show References

Granfeldt A, Kirgegaard BL, Vallentin MF et al. Sodium bicarbonate for in-hospital cardiac arrest: a randomized clinical trial. JAMA. 2026;336(8):647-654. doi:10.1001/jama.2026.10628



Title: Tourniquet conversion

Category: Trauma

Posted: 11/8/2026 by Robert Flint, MD (Updated: 11/19/2026)

Tourniquets can be life saving. Studies do show they are often unnecessarily applied. Tourniquet time is associated with limb salvageability. For those that practice in an environment where immediate vascular or trauma surgery isn’t available, the ability to convert a tourniquet to a less restrictive process can be limb saving. 
This review suggests: “tourniquet conversion requires a controlled, slow release (generally over 1–2 min, followed by at least 2 minutes of direct pressure to the wound with a moist dressing) to assess for ongoing hemorrhage while balancing the competing risks of rebleeding and reperfusion-associated complications. Conversion is generally recommended in patients who are hemodynamically stable, without traumatic amputation, and in whom the wound can be closely monitored for recurrent hemorrhage.”

Show References

Journal of Trauma and Acute Care Surgery 101(5):p 711-722, November 2026. | DOI: 10.1097/TA.0000000000005108



Title: To treat or not to treat

Category: Cardiology

Posted: 11/7/2026 by Robert Flint, MD (Updated: 11/19/2026)

Doesn’t really seem to be the question. This  meta analysis found no benefit in treating asymptomatic (and no evidence of end organ dysfunction) hypertensive ED pts. There was a signal to harm in treating inpatients.

Show References

Tangpaisarn, T., Wongtanasarasin, W., Na Thalang, K. et al. Acute pharmacologic treatment versus observation for severe asymptomatic hypertension in emergency and acute care settings: a systematic review of short-term outcomes. BMC Emerg Med (2026). https://doi.org/10.1186/s12873-026-01786-3



Title: Heimlich Heist? Updates on the management of severe airway foreign body obstructions

Category: Pediatrics

Keywords: severe airway foreign body obstruction, heimlich, back blows, chest thrusts (PubMed Search)

Posted: 11/6/2026 by Mary Girgis, MD

new AHA guidelines recommend changes to standard of care for pediatric severe airway foreign body obstructions

Show Additional Information

Key changes: 

-A recent observational study of adult and pediatric FBAO suggests improved clearance of a foreign body with the use of back blows over abdominal thrusts

-To create consistency for instructional purposes, and in the absence of inferiority from pediatric data, management of severe FBAO in children now starts with a series of back blows instead of abdominal thrusts. Repeated cycles of 5 back blows followed by 5 abdominal thrusts are performed until the obstruction is cleared or the child becomes unresponsive.

-Abdominal thrusts are not recommended for infants, given the potential to cause abdominal organ injury

-The risk of blind finger sweeps outweighs any potential benefit in the management of FBAO

Show References

https://publications.aap.org/pediatrics/article/157/1/e2025074350/205235/Part-6-Pediatric-Basic-Life-Support-2025-American

Dunne CL, Cirone J, Blanchard IE, Holroyd-Leduc J, Wilson TA, Sauro K, McRae AD. Evaluation of basic life support interventions for foreign body airway obstructions: A population-based cohort study. Resuscitation. 2024 Aug;201:110258. doi: 10.1016/j.resuscitation.2024.110258. Epub 2024 May 31. PMID: 38825222.



Title: We’re Safe! Maybe AI won’t replace us!

Category: Administration

Keywords: Artificial Intelligence, large language model, Author's Framework (PubMed Search)

Posted: 11/6/2026 by Steve Schenkel, MD, MPP (Updated: 11/19/2026)

Rose and colleagues used a framework (Autor’s Framework) developed in labor economics to evaluate the work of the emergency physician and the potential for replacement by AI. Mapping emergency physician tasks to a four-quadrant grid, they found that most time on shift is spent in non-routine abstract or manual tasks, areas more protected from AI penetration.

Rose C, Molins E, Schoeffler A, Kabeer R, Frank MR, Preiksaitis C. Will Artificial Intelligence Replace Me? Automation Susceptibility of Emergency Physician Tasks; Annals of Emergency Medicine, 2026; 88, 551-561.



Title: Decrease MOUD during pregnancy?

Category: Toxicology

Posted: 11/5/2026 by Robert Flint, MD (Updated: 11/5/2026)

This study found no reason to decrease pregnant women’s dosing of medication for opiate use disorder. There was no increase in neonatal withdrawal with standard dosing vs decrease dosing. 
As with most things, what is good for mom is good for baby. Keeping mom from relapsing  to opiate use is the number one goal of MOUD.

Show References

Townsel C, Turner M, Biroon F, et al. Umbilical Cord Methadone and Buprenorphine Levels and Neonatal Opioid Withdrawal Severity. JAMA Netw Open. 2026;9(10):e2641876. doi:10.1001/jamanetworkopen.2026.41876



Title: "There are no old bold mushroom hunters"

Category: Toxicology

Keywords: Amatoxin, Amanita phalloides, mushroom poisoning (PubMed Search)

Posted: 11/5/2026 by Kathy Prybys, DO (Updated: 11/5/2026)

About Death Cap - Maryland Biodiversity Project

45 year old male presents with nausea, vomiting, profuse diarrhea, and abdominal cramping  occurring 6-7 hours after eating a meal he cooked containing wild mushrooms he picked the day before. What is you diagnosis?

Show Additional Information

Answer: 

Amanita containing mushroom ingestion. Amanita phalloides ( aka: death cap) contains a highly potent hepatotoxin responsible for 90% of mushroom fatalities worldwide.

Foraging and misidentification for edible is the primary source of exposure. Obtaining a history of mushroom ingestion, identifiying species, and early treatment are critical to improve outcomes.

Gastrointestinal symptoms occurring 6 hours or later after eating a wild or unknown mushrooms should be considered a serious life threatening emergency. Assume to due to an amatoxin containing mushroom and start treatment.

Amanita phalloides have white, greenish,or yellow tinted caps, broad gills free from stem, white spores, a ring or skirt of tissue near top of stem, and most importantly a bulbous base that sits in a cup-like sac.

Amatoxins are highly potent cyclopeptides with a fatal dose in adults of 0.1 mg /kg (approx.1/2  mushroom). Amatoxins are found in all parts of mushrooms and are markedly stable, resistant to cooking, freezing, drying, enzymes, or pH changes. Alpha-amantin, one of the most powerful amatoxins, is rapidly absorbed in the gut and transported into hepatocytes by an organic anion transporting polypeptide (OATP1B3 transporter) where it irreversibly binds RNA polymerase II, preventing protein synthesis and causing cell necrosis.

Triphasic toxicity:

  1. Delayed GI phase (6-24 hours) : Initially no symptoms for 6-12 hours followed by nausea, vomiting, profuse diarrhea, and abdominal cramping 
  2. Symptomatic recovery (24-36 hours) with false sense of recovery: subclinical rise liver transaminases
  3. Hepatorenal phase ( 3-7 days) : Acute liver and renal failure

 November 2025-March 2026 after a late average to above average rainfall which resulted in super blooms of wild mushrooms there was an outbreak of 39 cases of amatoxin mushroom poisoning in northern California resulting in 3 liver transplantations and 4 deaths.

Comprehensive Treatment Approach: No single antidote or consensus on treatment protocol 

  • Decontamination: single or multi dose activated charcoal to bind toxin and disrupt enterohepatic recirculation
  • Aggressive IV hydration:  promotes amatoxin elimination by kidneys and corrects GI volume loss 
  • N-acetylcysteine (NAC): antioxidant effects, 21 hour protocol
  • Silibinin (milk thistle extract) : prevents uptake of amatoxin by hepatocytes cells by inhibition OATP transporter.  Oral available at health food stores. In US, intravenous (branded  Legalon SIL) not available in hospitals but is available by contacting the FDA emergency investigational new drug program and manufacturer. 5 mg/kg loading dose over 1 hour followed by continuous infusion 20 mg/kg/day 
  • Octreotide infusion: minimize gallbladder contraction and slow enterohepatic recirculation. 50 mcg/hour IV
  • HD Penicillin: Used historically can be used as alternative OATP inhibitor. 1 million units/kg divided qid
  • Cyclosporine:  Promising highly potent OATP1B3. Readily available in IV  5 mg/kg IV over 4-6 hours every 24 hours
  • CRRT/HD 
  • Liver transplant

Show References

Amanita Species mushroom poisonings-Northern California, November 2025-March 2026. Brandecker KJ, Haymanc, et al. MMWR Morb Mortal Wkly Rep 2026;75:258-263. DOI: https://dx.doi.org/10.15585/mmwr.mm7520a2

Cyclosporine as a novel treatment for amatoxin-containing mushroom poisoning: a case series. Mackenzie, C. A., Austin, E., Thompson, et al. (2022). Toxicology Communications, 6(1), 23–27. https://doi.org/10.1080/24734306.2021.2006957



Title: When do I start vasopressin again?

Category: Critical Care

Keywords: Vasopressors, norepinephrine, vasopressin, shock, sepsis, septic shock, VASSPR (PubMed Search)

Posted: 11/3/2026 by Mark Sutherland, MD

Norepinephrine is widely viewed as the first line vasopressor for many types of shock, including undifferentiated shock and septic shock.  But as the norepinephrine dose escalates, a perennial question is when to add a second agent, most commonly vasopressin.  Based in part on trials like VASST and VANISH, a norepinephrine dose of roughly 0.1-0.2 mcg/kg/min is commonly cited as the time to add on vasopressin.  

The VASSPR study was a cluster crossover randomized trial comparing lower (0.1 mcg/kg/min of norepinephrine) vs higher (0.4 mcg/kg/min of norepinephrine) threshold for initiation vasopressin in septic shock patients and was published in JAMA just a few weeks ago.  

Bottom Line: This relatively large, high-quality study found no mortality benefit for initiating vasopressin when at a norepinephrine dose of 0.1 mcg/kg/min (or equivalent), which is a common practice, vs initiating vasopressin when at a norepinephrine dose of 0.4 mcg/kg/min.  So whether you choose to stick with the current threshold of roughly 0.1-0.2 of norepi that many of us use as your queue to start a second agent, or wait a little later up to 0.4, that's a reasonable approach.  Equipoise remains as to the benefit of adding a second agent and when it should be initiated.  Of note, the surviving sepsis guidelines say 0.25-0.5 mcg/kg/min, so you also have support from those guidelines if you choose to wait.

Show References

https://jamanetwork.com/journals/jama/article-abstract/2855462



Title: AAA measurement

Category: Ultrasound

Keywords: AAA, vascular, critical care (PubMed Search)

Posted: 11/2/2026 by Alexis Salerno Rubeling, MD (Updated: 11/19/2026)

Question

A male in his 70s presents to the emergency department after a syncopal episode with hypotension and abdominal pain.

What's the diagnosis? What's the correct measurement?

Show Answer

This patient has a AAA with a large mural thrombus. The patient is symptomatic and there is concern for aortic rupture.

POCUS has a high sensitivity and specificity for diagnosing AAA but is still limited in diagnosing rupture. 

The highest risk of rupture is in those with AAAs > 5.5 cm in males and 5.0 cm in females. 

Remember to correctly measure the aorta by including the mural thrombus in your measurement. Mural thrombus presence has been associated with higher growth rates and increased risk of rupture. 

Show References

Jeffers K, Keim SM, et al. What is the Utility of Point-of-Care Ultrasound for Diagnosing Abdominal Aortic Aneurysm? J Emerg Med. 2026 Mar;82:82-87. doi: 10.1016/j.jemermed.2025.12.006.



Title: Pigtails

Category: Trauma

Posted: 11/1/2026 by Robert Flint, MD (Updated: 11/19/2026)

This review article reminds us that pigtail catheters can be effectively used to drain pneumothoraces, pleural effusions, hemothoraces, emphysemas, and other fluid collections within the thorax. It also offers three patient positions to use for pigtail placement. 

 

Show References

September 16, 2026. doi:10.1001/jamasurg.2026.4169



Title: More than Just Cycling Another Pressure: TRICYCLE trial

Category: Critical Care

Keywords: vasopressor, norepinephrine, vasopressin, angiotensin II, circulatory shock, septic shock (PubMed Search)

Posted: 10/27/2026 by Zach Wynne, MD

Bottom Line:

This multicenter trial demonstrated improved physiological outcomes such as lactate clearance and renin clearance in septic shock by using early multimodal vasopressor strategy but was not powered to detect mortality benefit. Further studies looking at more patient specific outcomes with this strategy are needed.

When caring for a critically ill ICU boarder in the ED, remember to add vasopressin early for escalating norepinephrine requirements (0.2-0.3 mcg/kg/min NEE).

Show Additional Information

TRICYCLE trial - Critical Care, Sept 2026

Background:

Vasopressor use in critically ill patients is common and typically follows a stepwise additive approach (norepinephrine, then vasopressin, then epinephrine and adjuncts). However, circulatory shock represents a failure of multiple hormonal mechanisms involved in vascular tone and macroperfusion. We typically don't use only one type of blood pressure medicine to treat hypertension; why do we use only one vasopressor to treat shock? The evidence remains mixed with a recent meta-analysis from AJEM showing decreased hospital length of stay but no mortality difference with the early addition of vasopressin. 

The authors of the TRICYCLE paper sought to see if the use of early multimodal vasopressor therapy in septic shock would accelerate improvement in biomarkers and decrease overall vasopressor requirement in septic shock.

Patients: 18+ years old with sepsis and hypotension requiring vasopressors to maintain MAP of 65 mmHg or greater and serum lactate > 2 mmol/L despite adequate volume resuscitation. Patients needed a vasopressor requirement of minimum 0.15 mcg/kg/min norepinephrine equivalent dose and a cardiac index of greater than 2.3 L/min/m2. 

Exclusions included death in 24 hrs, pregnancy, need for surgery or inter-hospital transfer, liver failure with MELD > 30, mesenteric ischemia, active bleeding or expected need for MTE, and VA-ECMO.

Intervention: “Tricycle therapy” defined as initiation of norepinephrine at 0.15 mcg/kg/min, vasopressin at 0.015 IU/min, and angiotensin II at 20 ng/kg/min, titrated by a defined regimen to a MAP 65-75 mmHg.

Control: Conventional vasopressor titration starting with norepinephrine, then adding vasopressin at higher doses of norepinephrine, and then adding additional vasopressors. In both groups, additional inotropes and vasopressors could be used at the treating physician's discretion.

Outcome: Primary outcome was change in plasma renin concentration (another tissue perfusion marker with growing evidence of association with ICU mortality) within 72 hours. Secondary outcomes included change in lactate concentration within 72 hours and change in SOFA score between days 1 and 3. There were several exploratory outcomes as well including mortality.

Results:

79 total patients were randomized with similar baseline characteristics between the groups except baseline renin and lactate concentrations were higher in the intervention group. Renin declined 2.61%/hour in the intervention group vs. 1.67%/hour in the control group (p=0.015), with 72-hour reduction of 46.9% in intervention vs. 33.2% in control group. Lactate declined similarly with 72-hour reduction of 30.9% in intervention vs. 21.7% in control (p=0.006 for per hour comparison). SOFA score changed by -3 in intervention vs. 0 in control (p=0.018). 

There was no difference in mortality and renal replacement therapy. There was a statistically significant decrease in norepinephrine equivalent dose requirements at 24 hours in the intervention vs. control group (81.9% vs. 52.3%, p<0.0004). Tachyarrhythmias were statistically significantly less in the intervention vs. control group (15.6% vs. 68.6%, p< 0.01).

Discussion:

Overall, this trial was more exploratory but did find improved lactate and renin clearance with an initial multimodal approach to vasopressors in patients with septic shock. However, larger trials are needed to look at outcomes such as incidence of tachyarrhythmias, need for renal replacement therapy, or other patient-related outcomes prior to using this approach clinically.

However, this paper falls in line with other evidence supporting the early use of vasopressin in your ED ICU boarders (typically around norepinephrine doses of 0.2-0.3 mcg/kg/min) as noted in Surviving Sepsis 2026 Guidelines, supporting this multi-mechanism approach.

Show References

  • Kalamar Ž, Landoni G, Gorenjak M, Cestar I, Fluher J, Horvat M, Jerenec K, Kit B, Marinšek M, Puklavec N, Svenšek F, Radoni? R, Šundali? S, Brajkovi? AV, Vujevi? A, Erjavc N, Petek D, Košir AS, Homšak E, Knehtl MC, Markota A. Early multimodal vasopressor strategy in septic shock: results of the TRICYCLE randomized controlled trial. Crit Care. 2026 Sep 7;30(1):508. doi: 10.1186/s13054-026-06323-z. PMID: 42827265; PMCID: PMC13633629.
  • Mamede I, Arêa L, Carvalhal G, Bessa R, Lenzi M, Dos Santos MCF. Early vasopressin plus norepinephrine versus delayed or no vasopressin in septic shock: A systematic review and meta-analysis. Am J Emerg Med. 2026 Jan;99:225-231. doi: 10.1016/j.ajem.2025.10.003. Epub 2025 Oct 5. Erratum in: Am J Emerg Med. 2026 Jul;105:202. doi: 10.1016/j.ajem.2026.04.001. PMID: 41067173.
  • Gleeson, P. J., Crippa, I. A., Mongkolpun, W., Cavicchi, F. Z., Van Meerhaeghe, T., Brimioulle, S., Taccone, F. S., Vincent, J.-L., & Creteur, J. (2019). Renin as a Marker of Tissue-Perfusion and Prognosis in Critically Ill Patients*. Critical Care Medicine, 47(2), 152–158. https://doi.org/10.1097/CCM.0000000000003544
  • Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., Evans, L., Gershengorn, H. B., Hodgson, C. L., Honarmand, K., Kesecioglu, J., McIntyre, L., Mer, M., Nunnally, M. E., Oczkowski, S. J. W., … Coopersmith, C. M. (2026). Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Critical Care Medicine, 54(4), 725–812. https://doi.org/10.1097/CCM.0000000000007075


Title: Hypoxic and Anemic: What Are You Missing?

Category: Critical Care

Keywords: diffuse alveolar hemorrhage, DAH, anemia, hypoxia (PubMed Search)

Posted: 10/26/2026 by Lena Carleton, MD (Updated: 10/26/2026)

A patient presents with hypoxia, anemia, and the following CT findings: 

What is the diagnosis? What will you do next?

Show Additional Information

Diffuse alveolar hemorrhage (DAH) is a clinicopathologic syndrome caused by bleeding from the pulmonary microcirculation into the alveolar spaces. It classically presents with hemoptysis, anemia, hypoxic respiratory failure, and diffuse pulmonary infiltrates. However, patients do not need to have all four features, and up to one-third of patients will present without hemoptysis. When DAH is suspected clinically, bronchoscopy with bronchoalveolar lavage can help confirm the diagnosis by demonstrating progressively bloodier return across sequential aliquots. CT will show diffuse ground-glass opacities, and may also demonstrate subpleural sparing and a dark bronchus sign.

DAH results from an underlying disease process or trigger, such as an autoimmune disease, infection, medication, toxin, or other exposure. Treatment combines supportive care with therapies directed at the underlying cause, which may include high-dose corticosteroids, other immunomodulatory agents, and antibiotics.

Show References

Weerakkody Y, Knipe H, Walizai T, et al. Diffuse alveolar hemorrhage. Reference article, Radiopaedia.org (Accessed on 23 Oct 2026) https://doi.org/10.53347/rID-19690

Lutz, J.R., Martínez-Brocato, E., Segura-Martínez, S.V. et al. Clinical, radiological and laboratory features and outcomes of diffuse alveolar hemorrhage. Sci Rep 16, 8643 (2026). https://doi.org/10.1038/s41598-026-41864-x

Attachments

  • Screenshot 2026-10-23 at 10.41.33?AM-6adb72e534f46.png (612 Kb)


Title: Firearm conversations

Category: Geriatrics

Posted: 10/25/2026 by Robert Flint, MD (Updated: 11/19/2026)

As a reminder,  age friendly health care says we should address the 4Ms with older patients; what matters, medication, mentation, and mobility.

This article says we aren’t good about discussing firearm access with older depressed patients and patients with dementia. We can do better having these conversations with our vulnerable older patients and their families.

Show References

Lena K. Makaroun
%A Timothy W. Farrell
%A Marian E. Betz
%T Firearm-Related Discussions as an Age-Friendly Intervention
%D 2026
%J New England Journal of Medicine
%P 1461-1463
%V 395
%N 15
%R doi:10.1056/NEJMp2608481
%U https://www.nejm.org/doi/full/10.1056/NEJMp2608481
%X Older adults are vulnerable to firearm-related harms. Medicare’s annual wellness visit presents an opportunity to engage older adults and their families or caregivers in conversations about firearms.



Previous |  1 |  2 |  3 |  4 |  5 |  6 |  ... |  241 |  Next
University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map